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Introduction
A large proportion of ICU patients suffer from respira-
tory virus infections. This is often complicated by sec-
ondary infections, suggesting increased vulnerability in
these patients. Recent work has shown that in bacterial
sepsis, a immunosuppressive state called “immunopara-
lysis” accounts for this increased vulnerability. However,
virus-induced immunoparalysis is largely unstudied.
Human Rhinoviruses (HRVs) are the most frequent
cause of the common cold. The “experimental cold
model” is widely used to investigate the pathogenesis of
HRV infection. However, the effects of repeated HRV
exposure and thus possible development of virus-
induced immunoparalysis have never been studied.
Furthermore, although the virulent HRV-C can cause
systemic and severe infections in both children and
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adults and the less virulent HRV-A strain can cause
severe infections in immunocompromised patients as
well, the HRV-A-induced systemic inflammatory and
lower respiratory tract effects have never been studied
in healthy subjects. Finally, it remains to be determined,
whether serostatus alters the HRV-induced inflamma-
tory response.
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Objectives
1. To investigate the effects of serostatus and repeated
HRV exposure on the HRV-induced inflammatory
response.
2. To assess HRV-induced systemic inflammatory and
lower respiratory tract effects.
Methods
In this randomized, double-blind, placebo-controlled
study, 40 healthy, non-smoking, non-asthmatic male and
female (1:1) subjects (seronegative: n = 22, seropositive:
n = 18) were inoculated with HRV-16 (HRV-A) (n = 20)
or placebo (n = 20). One week later, all subjects were
inoculated with HRV-16. Nasal wash, blood samples and
peak expiratory flow were obtained daily.
Results
HRV-inoculation resulted in an infection rate of 82%. In
seropositive subjects, HRV infection did not cause a
local or systemic inflammatory response. In seronegative
subjects, HRV infection resulted in increased levels of
CXCL-10 (both in plasma and nasal wash), IL-6, IL-8,
and IL-10 (in nasal wash). Despite similar viral load
(Figure 1, upper panels), levels of CXCL-10 and IL-6 in
nasal wash showed no increase but further declined
upon the second HRV inoculation, and a similar trend
was observed for IL-10 (Figure 2). Furthermore, the
increase in plasma CXCL-10 levels observed after the
first HRV inoculation was abolished upon the second
HRV inoculation (Figure 1, lower panels). HRV infection
did not affect peak expiratory flow.
Conclusions
HRV infection does not result in an inflammatory
response in seropositive subjects and exerts no effects
on the lower respiratory tract. Furthermore, a second
inoculation with HRV one week after the first results in
a diminished local and systemic inflammatory response.
This could be an explanation for the increased vulner-
ability towards secondary infections after respiratory
virus infections in ICU patients.
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